Clinical Trial Update: Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

Clinical trial update examining the effect of the DPP-4 inhibitor sitagliptin on islet function after a mixed meal in adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: Lund University | Conditions: Type 2 Diabetes | NA | Status: COMPLETED